These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7805705)

  • 21. [The local anesthetic activity of inclusion compounds of pirbentan and trimecaine with beta-cyclodextrin].
    Kuiantseva AM; Kompantseva EV; Lukashova LA; Zakrzhevskaia TN
    Eksp Klin Farmakol; 1995; 58(3):20-2. PubMed ID: 7663287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Raman and solid state 13C-NMR investigation of the structure of the 1 : 1 amorphous piroxicam : beta-cyclodextrin inclusion compound.
    Redenti E; Zanol M; Ventura P; Fronza G; Comotti A; Taddei P; Bertoluzza A
    Biospectroscopy; 1999; 5(4):243-51. PubMed ID: 10478955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inclusion complex of piroxicam with beta-cyclodextrin and incorporation in cationic microemulsion. In vitro drug release and in vivo topical anti-inflammatory effect.
    Dalmora ME; Dalmora SL; Oliveira AG
    Int J Pharm; 2001 Jul; 222(1):45-55. PubMed ID: 11404031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Beta-cyclodextrin-piroxicam in the treatment of the active phase of osteoarthritic pathology].
    La Montagna G; Parenti M; Oliani C; Filippi F; Tirri G
    Riv Eur Sci Med Farmacol; 1990; 12(4-5):265-72. PubMed ID: 2103967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and gastrointestinal tolerability of beta-cyclodextrin-piroxicam and tenoxicam in the treatment of chronic osteoarthritis.
    Bonardelli P; Oliani C; Monici Preti PA; Pellicanó P; Quattrocchi G
    Clin Ther; 1990; 12(6):547-55. PubMed ID: 2289222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex.
    Jug M; Bećirević-Laćan M; Cetina-Cizmek B; Horvat M
    Pharmazie; 2004 Sep; 59(9):686-91. PubMed ID: 15497750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A structural study of the inclusion compound of piroxicam with beta-cyclodextrin by NMR].
    Miao ZC; Du ZH; Xu GF; Shi TS
    Yao Xue Xue Bao; 1988; 23(9):682-7. PubMed ID: 3256202
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of pH dependent molecular conformation and dimerization phenomena of piroxicam on the drug:cyclodextrin complex stoichiometry and its chromatographic behaviour. A new specific HPLC method for piroxicam:cyclodextrin formulations.
    Rozou S; Voulgari A; Antoniadou-Vyza E
    Eur J Pharm Sci; 2004 Apr; 21(5):661-9. PubMed ID: 15066667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Application of beta-cyclodextrin inclusion complex in liushen pills].
    Wang XP; Liao GT; Hou SX; Wang CM
    Zhongguo Zhong Yao Za Zhi; 1993 Jul; 18(7):415-8, 447. PubMed ID: 8267855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of piroxicam beta-cyclodextrin complex on experimental inflammation.
    Amado CA; Taniguchi SF; Sudo LS; Kimura E; Oga S
    Gen Pharmacol; 1995 Jul; 26(4):809-13. PubMed ID: 7635256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiostatic steroids potentiated by sulfated cyclodextrins inhibit corneal neovascularization.
    Li WW; Casey R; Gonzalez EM; Folkman J
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2898-905. PubMed ID: 1917393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of cyclodextrin complexation on piroxicam gel formulations.
    Jug M; Bećirević-Laćan M; Kwokal A; Cetina-Cizmek B
    Acta Pharm; 2005 Sep; 55(3):223-36. PubMed ID: 16375834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do non-steroidal anti-inflammatory drugs influence chronic inflammation? The effects of piroxicam on chronic antigen-induced arthritis in rats.
    Sigurdardottir SL; Freysdottir J; Vikingsdottir T; Valdimarsson H; Vikingsson A
    Scand J Rheumatol; 2008; 37(6):469-76. PubMed ID: 19005999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclodextrin enhanced transdermal delivery of piroxicam and carboxyfluorescein by electroporation.
    Murthy SN; Zhao YL; Sen A; Hui SW
    J Control Release; 2004 Oct; 99(3):393-402. PubMed ID: 15451597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of efficacy of nizer versus nimesulide tablets in otitis media.
    Dasgupta KS; Deshpande AS; Vedi JN; Patel S
    J Indian Med Assoc; 2002 Oct; 100(10):619. PubMed ID: 12452517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.
    Jacoby RF; Cole CE; Tutsch K; Newton MA; Kelloff G; Hawk ET; Lubet RA
    Cancer Res; 2000 Apr; 60(7):1864-70. PubMed ID: 10766173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Metabolic destination and toxicologic profile of hydroxypropyl beta-cyclodextrin].
    Giordano F
    Boll Chim Farm; 1991 Jun; 130(6):239-40. PubMed ID: 1756008
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of the combined oral administration of NSAIDs and dextromethorphan on behavioral symptoms indicative of arthritic pain in rats.
    Price DD; Mao J; Lu J; Caruso FS; Frenk H; Mayer DJ
    Pain; 1996 Nov; 68(1):119-27. PubMed ID: 9252006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biopharmaceutics of local anesthetic-cyclodextrin complexes following loco-regional administration].
    Dollo G; Le Corre P; Fréville JC; Chevanne F; Leverge R
    Ann Pharm Fr; 2000 Dec; 58(6):425-32. PubMed ID: 11148378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on the pharmacokinetic-pharmacodynamic model of ketoprofen beta-CD inclusion complex in rabbits].
    Lu W; Tu X; Wu G
    Yao Xue Xue Bao; 1998 Nov; 33(11):855-9. PubMed ID: 12016948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.